The Wegovy 1.7mg click chart — and why clicks aren't the whole story

The biggest misconception: Wegovy pens use clicks like Ozempic pens do

This is the misunderstanding that brings most people to this search. Multi-dose semaglutide pens (most commonly Ozempic, which is licensed for type 2 diabetes rather than weight loss) require the user to dial the dose by turning the pen until a certain number of clicks are counted. A click chart maps those clicks to milligrams. That system makes sense for a pen that contains several doses across different appointments.

Wegovy works differently. Each Wegovy pen is a single-dose, pre-set device. When your prescriber moves you to the 1.7mg step, you receive pens that contain exactly 1.7mg. You press the button, the injection is delivered, and the pen is done. There is no dial, no click sequence and no chart to follow. The pen locks after use. Counting clicks on a Wegovy pen would not change or confirm your dose, it would simply count the mechanism engaging.

This distinction matters practically. If you've come across a Wegovy 1.7mg click chart shared in a forum or social media group, it was almost certainly written about Ozempic or an older semaglutide pen format. Applying it to your Wegovy pen could give you false reassurance or, worse, lead you to believe something has gone wrong with a perfectly normal injection. When in doubt, the Patient Information Leaflet inside the box is the authoritative guide for your specific pen.

How the 1.7mg step fits into the Wegovy titration schedule

Semaglutide for weight management follows a gradual dose escalation, and understanding where 1.7mg sits helps make sense of the whole journey. The licensed schedule runs: 0.25mg for four weeks, then 0.5mg, then 1mg, then 1.7mg, before reaching the 2.4mg maintenance dose, each step lasting approximately four weeks. The slow ascent exists to give your body time to adjust; side effects such as nausea tend to be most noticeable in the first days after a dose increase and usually ease as your system settles.

The 1.7mg step is not a destination. It sits one rung below the standard 2.4mg maintenance level, and most people move through it as a bridge rather than stopping there. Whether you stay at 1.7mg or progress is a clinical decision, your prescriber considers how you're tolerating the current dose and whether any side effects need more time to resolve. Some people do remain at 1.7mg for longer than four weeks if that's what their prescriber judges appropriate. You can read more about the full range of Wegovy doses and what each step involves.

If you're thinking about what comes next, the 2.4mg maintenance dose is covered separately, including how its pen compares to earlier steps in the schedule. For a closer look at how the 1.7mg Wegovy pen behaves in practice, including why the click question comes up so often at this stage, we cover that in detail on its own page.

What to do if your 1.7mg pen doesn't seem to be working correctly

It's understandable to feel uncertain the first time you use a new pen strength. The mechanisms are quiet, the dose is invisible, and (unlike swallowing a tablet) there's no obvious confirmation that the medicine went in. This is one of the things patients most commonly ask about, and it's worth saying plainly: if you pressed the button all the way down and held it for the count recommended in your leaflet, the injection almost certainly delivered.

Common concerns include not feeling a plunge, seeing a small droplet at the needle tip after injection, or wondering whether the needle was in far enough. The Patient Information Leaflet included with your Wegovy pen addresses each of these scenarios step by step, it is specific to your pen's design in a way that any generic chart cannot be. If you're genuinely unsure whether a dose was delivered correctly, contact your prescriber or pharmacist before injecting again; doubling up is not the answer.

For questions about your injection technique, storage or what to do if you miss a dose, our frequently asked questions page covers the most common queries, and our prescribers are reachable for aftercare support seven days a week. Information on the broader treatment context is also on our Wegovy overview page.

A note on pens sold outside normal clinical channels

The proliferation of click charts online is partly a product of the grey market for semaglutide. When people obtain multi-dose pens through routes that bypass a proper prescription (sometimes without any clinical assessment at all) they rely on community-shared instructions because there's no prescriber to ask. The MHRA has warned repeatedly about fake and illegally sold weight-loss pens, some of which have contained insulin rather than semaglutide, with serious consequences for people who used them. Authentic Wegovy pens, obtained through a GPhC-registered pharmacy following a proper clinical assessment, come with full labelling, a Patient Information Leaflet and a prescriber you can contact. That's the practical value of the legitimate route, not just legal compliance, but having someone to call when you're not sure.

If you'd like to understand more about what private treatment involves and whether you might be eligible, our clinical team page explains how our prescribers work, and you can compare your options on our weight-loss treatments overview. For context on private treatment costs, our Wegovy cost guide sets out what legitimate pricing typically includes. When you're ready, check your eligibility with a free consultation, a GPhC-registered prescriber reviews every application the same day.